tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Keros Therapeutics announces first patient dosed in Phase 3 RENEW trial
PremiumThe FlyKeros Therapeutics announces first patient dosed in Phase 3 RENEW trial
13d ago
Buy Rating for Takeda Pharmaceutical Driven by Successful Phase 3 Trials of Oveporexton
Premium
Ratings
Buy Rating for Takeda Pharmaceutical Driven by Successful Phase 3 Trials of Oveporexton
15d ago
Morning Movers: Sonnet BioTherapeutics skyrockets after $888M combination
Premium
The Fly
Morning Movers: Sonnet BioTherapeutics skyrockets after $888M combination
16d ago
Takeda’s 2025 Report Highlights Strong Growth and Leadership Transition
PremiumCompany AnnouncementsTakeda’s 2025 Report Highlights Strong Growth and Leadership Transition
1M ago
Takeda announces FDA approval of Gammagard Liquid ERC
Premium
The Fly
Takeda announces FDA approval of Gammagard Liquid ERC
1M ago
Takeda Completes Share Repurchase Program in May 2025
Premium
Company Announcements
Takeda Completes Share Repurchase Program in May 2025
2M ago
Veeva price target raised to $300 from $270 at Needham
PremiumThe FlyVeeva price target raised to $300 from $270 at Needham
2M ago
Takeda Reports Changes in Subsidiaries and Associates as of May 28, 2025
Premium
Company Announcements
Takeda Reports Changes in Subsidiaries and Associates as of May 28, 2025
2M ago
Takeda Announces CEO Succession and Advocates for Healthcare Reforms
Premium
Company Announcements
Takeda Announces CEO Succession and Advocates for Healthcare Reforms
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100